|
EXAS | Exact Sciences Corp |
|
|
EXAS | Exact Sciences Corp |
| Services-Medical Laboratories |
| Book value per $ invested | $ 0.14 |
| Leverage | 57.60% |
| Market Cap | $ 18.3B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -986.4m |
| Margin | -32.05% |
Exact Sciences Corporation offers cancer screening and diagnostic test products in the United States and internationally. The company is headquartered in Madison, Wisconsin.